These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Delaware
|
|
94-3180138
|
|
(State or other jurisdiction of
incorporation or organization)
|
|
(I.R.S. Employer
Identification No.)
|
|
Large accelerated filer
|
|
¨
|
|
Accelerated filer
|
|
ý
|
|
|
|
|
|
|||
|
Non-accelerated filer
|
|
¨
(Do not check if a smaller reporting company)
|
|
Smaller Reporting Company
|
|
¨
|
|
|
|
|
|
Emerging Growth Company
|
|
¨
|
|
Title of each class
|
Trading Symbol
|
Name of each exchange on which registered
|
|
Common Stock, $0.001 par value
|
IMMR
|
NASDAQ Global Market
|
|
|
|
|
|
|
|
Page
|
|
|
|
|
|
Item 1.
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
Item 2.
|
||
|
|
|
|
|
Item 3.
|
||
|
|
|
|
|
Item 4.
|
||
|
|
|
|
|
|
||
|
|
|
|
|
Item 1.
|
||
|
|
|
|
|
Item 1A.
|
||
|
|
|
|
|
Item 6.
|
||
|
|
|
|
|
|
|
March 31, 2019
|
|
December 31, 2018
|
||||
|
ASSETS
|
|
|
|
|
||||
|
Current assets:
|
|
|
|
|
||||
|
Cash and cash equivalents
|
|
$
|
102,654
|
|
|
$
|
110,988
|
|
|
Short-term investments
|
|
14,959
|
|
|
13,930
|
|
||
|
Accounts and other receivables
|
|
1,505
|
|
|
1,051
|
|
||
|
Prepaid expenses and other current assets
|
|
8,774
|
|
|
9,856
|
|
||
|
Total current assets
|
|
127,892
|
|
|
135,825
|
|
||
|
Property and equipment, net
|
|
2,144
|
|
|
2,343
|
|
||
|
Other assets, net
|
|
18,445
|
|
|
7,827
|
|
||
|
Total assets
|
|
$
|
148,481
|
|
|
$
|
145,995
|
|
|
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
|
|
|
|
||||
|
Current liabilities:
|
|
|
|
|
||||
|
Accounts payable
|
|
$
|
12,375
|
|
|
$
|
3,612
|
|
|
Accrued compensation
|
|
1,360
|
|
|
3,948
|
|
||
|
Other current liabilities
|
|
6,314
|
|
|
3,194
|
|
||
|
Deferred revenue
|
|
4,816
|
|
|
4,591
|
|
||
|
Total current liabilities
|
|
24,865
|
|
|
15,345
|
|
||
|
Long-term deferred revenue
|
|
29,074
|
|
|
30,203
|
|
||
|
Other long-term liabilities
|
|
3,609
|
|
|
787
|
|
||
|
Total liabilities
|
|
57,548
|
|
|
46,335
|
|
||
|
Contingencies (Note 12)
|
|
|
|
|
||||
|
Stockholders’ equity:
|
|
|
|
|
||||
|
Common stock and additional paid-in capital — $0.001 par value; 100,000,000 shares authorized; 38,375,744 and 37,652,498 shares issued, respectively; 31,552,597 and 30,829,351 shares outstanding, respectively
|
|
248,698
|
|
|
246,415
|
|
||
|
Accumulated other comprehensive income
|
|
122
|
|
|
116
|
|
||
|
Accumulated deficit
|
|
(109,537
|
)
|
|
(98,521
|
)
|
||
|
Treasury stock at cost: 6,823,147 and 6,823,147 shares, respectively
|
|
(48,350
|
)
|
|
(48,350
|
)
|
||
|
Total stockholders’ equity
|
|
90,933
|
|
|
99,660
|
|
||
|
Total liabilities and stockholders’ equity
|
|
$
|
148,481
|
|
|
$
|
145,995
|
|
|
|
|
Three Months Ended March 31,
|
||||||
|
|
|
2019
|
|
2018
|
||||
|
Revenues:
|
|
|
|
|
||||
|
Royalty and license
|
|
$
|
5,047
|
|
|
$
|
85,335
|
|
|
Development, services, and other
|
|
75
|
|
|
81
|
|
||
|
Total revenues
|
|
5,122
|
|
|
85,416
|
|
||
|
Costs and expenses:
|
|
|
|
|
||||
|
Cost of revenues
|
|
15
|
|
|
35
|
|
||
|
Sales and marketing
|
|
1,609
|
|
|
1,220
|
|
||
|
Research and development
|
|
2,302
|
|
|
2,820
|
|
||
|
General and administrative
|
|
12,695
|
|
|
11,236
|
|
||
|
Total costs and expenses
|
|
16,621
|
|
|
15,311
|
|
||
|
Operating income (loss)
|
|
(11,499
|
)
|
|
70,105
|
|
||
|
Interest and other income
|
|
598
|
|
|
231
|
|
||
|
Income (loss) before provision for income taxes
|
|
(10,901
|
)
|
|
70,336
|
|
||
|
Provision for income taxes
|
|
(115
|
)
|
|
(453
|
)
|
||
|
Net income (loss)
|
|
$
|
(11,016
|
)
|
|
$
|
69,883
|
|
|
Basic net income (loss) per share
|
|
$
|
(0.35
|
)
|
|
$
|
2.35
|
|
|
Shares used in calculating basic net income (loss) per share
|
|
31,089
|
|
|
29,700
|
|
||
|
Diluted net income (loss) per share
|
|
$
|
(0.35
|
)
|
|
$
|
2.29
|
|
|
Shares used in calculating diluted net income (loss) per share
|
|
31,089
|
|
|
30,566
|
|
||
|
Other Comprehensive Income
|
|
|
|
|
||||
|
Change in unrealized gains on short-term investments
|
|
6
|
|
|
5
|
|
||
|
Total Other Comprehensive Income
|
|
6
|
|
|
5
|
|
||
|
Total Comprehensive Income (loss)
|
|
$
|
(11,010
|
)
|
|
$
|
69,888
|
|
|
|
Common Stock and
Additional Paid-In Capital |
|
Accumulated
Other Comprehensive Income (Loss) |
|
Accumulated
Deficit |
|
Treasury Stock
|
|
Total
Stockholders’ Equity |
||||||||||||||||
|
|
Shares
|
|
Amount
|
|
Shares
|
|
Amount
|
|
|||||||||||||||||
|
Balances at December 31, 2017
|
35,950,518
|
|
|
$
|
228,046
|
|
|
$
|
99
|
|
|
$
|
(171,616
|
)
|
|
6,685,690
|
|
|
$
|
(46,872
|
)
|
|
$
|
9,657
|
|
|
Net income
|
|
|
|
|
|
|
69,883
|
|
|
|
|
|
|
69,883
|
|
||||||||||
|
Unrealized gain on available-for-sale securities, net of taxes
|
|
|
|
|
5
|
|
|
|
|
|
|
|
|
5
|
|
||||||||||
|
Issuance of stock for ESPP purchase
|
13,834
|
|
|
98
|
|
|
|
|
|
|
|
|
|
|
98
|
|
|||||||||
|
Exercise of stock options, net of shares withheld for employee taxes
|
922,842
|
|
|
6,072
|
|
|
|
|
|
|
|
|
|
|
6,072
|
|
|||||||||
|
Release of restricted stock units and awards, including related stock compensation
|
156,781
|
|
|
|
|
|
|
|
|
|
|
|
|
|
—
|
|
|||||||||
|
Stock based compensation
|
|
|
1,222
|
|
|
|
|
|
|
|
|
|
|
1,222
|
|
||||||||||
|
Effect of change in accounting policy
(1)
|
|
|
|
|
|
|
18,335
|
|
|
|
|
|
|
18,335
|
|
||||||||||
|
Balances at March 31, 2018
|
37,043,975
|
|
|
$
|
235,438
|
|
|
$
|
104
|
|
|
$
|
(83,398
|
)
|
|
6,685,690
|
|
|
$
|
(46,872
|
)
|
|
$
|
105,272
|
|
|
|
Common Stock and
Additional Paid-In Capital |
|
Accumulated
Other Comprehensive Income (Loss) |
|
Accumulated
Deficit |
|
Treasury Stock
|
|
Total
Stockholders’ Equity |
||||||||||||||||
|
|
Shares
|
|
Amount
|
|
Shares
|
|
Amount
|
|
|||||||||||||||||
|
Balances at December 31, 2018
|
37,652,498
|
|
|
$
|
246,415
|
|
|
$
|
116
|
|
|
$
|
(98,521
|
)
|
|
6,823,147
|
|
|
$
|
(48,350
|
)
|
|
$
|
99,660
|
|
|
Net loss
|
|
|
|
|
|
|
(11,016
|
)
|
|
|
|
|
|
(11,016
|
)
|
||||||||||
|
Unrealized gain on available-for-sale securities, net of taxes
|
|
|
|
|
6
|
|
|
|
|
|
|
|
|
6
|
|
||||||||||
|
Issuance of stock for ESPP purchase
|
13,479
|
|
|
109
|
|
|
|
|
|
|
|
|
|
|
109
|
|
|||||||||
|
Exercise of stock options, net of shares withheld for employee taxes
|
11,771
|
|
|
71
|
|
|
|
|
|
|
|
|
|
|
71
|
|
|||||||||
|
Release of restricted stock units and awards, including related stock compensation
|
697,996
|
|
|
|
|
|
|
|
|
|
|
|
|
|
—
|
|
|||||||||
|
Stock based compensation
|
|
|
2,103
|
|
|
|
|
|
|
|
|
|
|
2,103
|
|
||||||||||
|
Balances at March 31, 2019
|
38,375,744
|
|
|
$
|
248,698
|
|
|
$
|
122
|
|
|
$
|
(109,537
|
)
|
|
6,823,147
|
|
|
$
|
(48,350
|
)
|
|
$
|
90,933
|
|
|
|
|
Three Months Ended March 31,
|
||||||
|
|
|
2019
|
|
2018
|
||||
|
Cash flows provided by (used in) operating activities:
|
|
|
|
|
||||
|
Net income (loss)
|
|
$
|
(11,016
|
)
|
|
$
|
69,883
|
|
|
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
|
|
|
|
|
||||
|
Depreciation and amortization
|
|
205
|
|
|
227
|
|
||
|
Stock-based compensation
|
|
2,103
|
|
|
1,222
|
|
||
|
Deferred income taxes
|
|
117
|
|
|
67
|
|
||
|
Other non cash items
|
|
—
|
|
|
26
|
|
||
|
Changes in operating assets and liabilities:
|
|
|
|
|
||||
|
Accounts and other receivables
|
|
(454
|
)
|
|
(1,861
|
)
|
||
|
Prepaid expenses and other current assets
|
|
1,028
|
|
|
116
|
|
||
|
Other assets
|
|
(11,419
|
)
|
|
(4,524
|
)
|
||
|
Accounts payable
|
|
8,763
|
|
|
(2,391
|
)
|
||
|
Accrued compensation
|
|
(2,588
|
)
|
|
(1,581
|
)
|
||
|
Other current liabilities
|
|
2,092
|
|
|
(600
|
)
|
||
|
Deferred revenue
|
|
(904
|
)
|
|
25,197
|
|
||
|
Other long-term liabilities
|
|
4,495
|
|
|
422
|
|
||
|
Net cash provided by (used in) operating activities
|
|
(7,578
|
)
|
|
86,203
|
|
||
|
Cash flows provided by (used in) investing activities:
|
|
|
|
|
||||
|
Purchases of short-term investments
|
|
(8,930
|
)
|
|
(8,861
|
)
|
||
|
Proceeds from maturities of short-term investments
|
|
8,000
|
|
|
11,000
|
|
||
|
Purchases of property and equipment
|
|
(6
|
)
|
|
(6
|
)
|
||
|
Net cash provided by (used in) investing activities
|
|
(936
|
)
|
|
2,133
|
|
||
|
Cash flows provided by financing activities:
|
|
|
|
|
||||
|
Proceeds from issuance of common stock under employee stock purchase plan
|
|
109
|
|
|
98
|
|
||
|
Proceeds from stock options exercises
|
|
71
|
|
|
6,072
|
|
||
|
Net cash provided by financing activities
|
|
180
|
|
|
6,170
|
|
||
|
Net increase (decrease) in cash and cash equivalents
|
|
(8,334
|
)
|
|
94,506
|
|
||
|
Cash and cash equivalents:
|
|
|
|
|
||||
|
Beginning of period
|
|
110,988
|
|
|
24,622
|
|
||
|
End of period
|
|
$
|
102,654
|
|
|
$
|
119,128
|
|
|
Supplemental disclosure of cash flow information:
|
|
|
|
|
||||
|
Cash paid for taxes
|
|
$
|
23
|
|
|
$
|
90
|
|
|
Supplemental disclosure of noncash operating, investing, and financing activities:
|
|
|
|
|
||||
|
Release of restricted stock units and awards under company stock plan
|
|
$
|
6,680
|
|
|
$
|
1,860
|
|
|
|
|
Three Months Ended March 31,
|
||||||
|
|
|
2019
|
|
2018
|
||||
|
Fixed fee license revenue
|
|
$
|
1,740
|
|
|
$
|
75,756
|
|
|
Per-Unit royalty revenue
|
|
3,307
|
|
|
9,579
|
|
||
|
Total royalty and license revenue
|
|
5,047
|
|
|
85,335
|
|
||
|
Development, services, and other revenue
|
|
75
|
|
|
81
|
|
||
|
Total revenues
|
|
$
|
5,122
|
|
|
$
|
85,416
|
|
|
|
|
March 31, 2019
|
|
|
||||||||||||
|
|
|
Fair Value Measurements Using
|
|
|
||||||||||||
|
|
|
Quoted Prices
in Active Markets for Identical Assets (Level 1) |
|
Significant
Other Observable Inputs (Level 2) |
|
Significant
Unobservable Inputs (Level 3) |
|
Total
|
||||||||
|
Assets:
|
|
|
|
|
|
|
|
|
||||||||
|
Money market accounts
|
|
$
|
70,848
|
|
|
—
|
|
|
—
|
|
|
$
|
70,848
|
|
||
|
U.S. Treasury securities
|
|
—
|
|
|
14,959
|
|
|
$
|
—
|
|
|
14,959
|
|
|||
|
Total assets at fair value
(1)
|
|
$
|
70,848
|
|
|
$
|
14,959
|
|
|
$
|
—
|
|
|
$
|
85,807
|
|
|
|
|
December 31, 2018
|
|
|
||||||||||||
|
|
|
Fair Value Measurements Using
|
|
|
||||||||||||
|
|
|
Quoted Prices
in Active
Markets for
Identical Assets
(Level 1) |
|
Significant
Other Observable Inputs (Level 2) |
|
Significant
Unobservable Inputs (Level 3) |
|
Total
|
||||||||
|
Assets:
|
|
|
|
|
|
|
|
|
||||||||
|
Money market accounts
|
|
$
|
81,425
|
|
|
—
|
|
|
—
|
|
|
$
|
81,425
|
|
||
|
U.S. Treasury securities
|
|
—
|
|
|
13,930
|
|
|
$
|
—
|
|
|
13,930
|
|
|||
|
Total assets at fair value
(2)
|
|
$
|
81,425
|
|
|
$
|
13,930
|
|
|
$
|
—
|
|
|
$
|
95,355
|
|
|
|
|
March 31, 2019
|
||||||||||||||
|
|
|
Amortized
Cost |
|
Gross
Unrealized Holding Gains |
|
Gross
Unrealized Holding Losses |
|
Fair
Value |
||||||||
|
U.S. Treasury securities
|
|
$
|
14,960
|
|
|
$
|
—
|
|
|
$
|
(1
|
)
|
|
$
|
14,959
|
|
|
Total
|
|
$
|
14,960
|
|
|
$
|
—
|
|
|
$
|
(1
|
)
|
|
$
|
14,959
|
|
|
|
|
December 31, 2018
|
||||||||||||||
|
|
|
Amortized
Cost |
|
Gross
Unrealized Holding Gains |
|
Gross
Unrealized Holding Losses |
|
Fair
Value |
||||||||
|
U.S. Treasury securities
|
|
$
|
13,936
|
|
|
$
|
—
|
|
|
$
|
(6
|
)
|
|
$
|
13,930
|
|
|
Total
|
|
$
|
13,936
|
|
|
$
|
—
|
|
|
$
|
(6
|
)
|
|
$
|
13,930
|
|
|
|
|
March 31, 2019
|
|
December 31,
2018
|
||||
|
Trade accounts receivable
|
|
$
|
967
|
|
|
$
|
645
|
|
|
Other receivables
|
|
538
|
|
|
406
|
|
||
|
Accounts and other receivables
|
|
$
|
1,505
|
|
|
$
|
1,051
|
|
|
|
|
March 31, 2019
|
|
December 31, 2018
|
||||
|
Contract assets - long-term
|
|
$
|
7,154
|
|
|
$
|
7,231
|
|
|
Lease assets
|
|
3,828
|
|
|
—
|
|
||
|
Deferred tax assets
|
|
295
|
|
|
295
|
|
||
|
Other assets
|
|
7,168
|
|
|
301
|
|
||
|
Total other assets
|
|
$
|
18,445
|
|
|
$
|
7,827
|
|
|
|
|
March 31, 2019
|
|
December 31, 2018
|
||||
|
Accrued legal
|
|
$
|
3,708
|
|
|
$
|
1,827
|
|
|
Lease liabilities - current
|
|
1,165
|
|
|
—
|
|
||
|
Income taxes payable
|
|
270
|
|
|
204
|
|
||
|
Other current liabilities
|
|
1,171
|
|
|
1,163
|
|
||
|
Total other current liabilities
|
|
$
|
6,314
|
|
|
$
|
3,194
|
|
|
|
|
March 31, 2019
|
|
|
Common stock shares available for grant
|
|
917
|
|
|
Stock options outstanding
|
|
2,268
|
|
|
RSAs outstanding
|
|
63
|
|
|
RSUs outstanding
|
|
801
|
|
|
|
|
Number of
Shares Underlying Stock Options |
|
Weighted
Average Exercise Price Per Share |
|
Weighted Average
Remaining Contractual Life (Years) |
|
Aggregate
Intrinsic Value |
|||||
|
Outstanding as of December 31, 2018
|
|
1,862
|
|
|
$
|
9.44
|
|
|
2.85
|
|
$
|
751
|
|
|
Granted
|
|
269
|
|
|
$
|
9.82
|
|
|
|
|
|
||
|
Exercises
|
|
(12
|
)
|
|
$
|
6.02
|
|
|
|
|
|
||
|
Cancelled or expired
|
|
(122
|
)
|
|
$
|
9.92
|
|
|
|
|
|
||
|
Outstanding as of March 31, 2019
|
|
1,996
|
|
|
$
|
9.48
|
|
|
2.77
|
|
$
|
361
|
|
|
Vested and expected to vest at March 31, 2019
|
|
1,996
|
|
|
$
|
9.48
|
|
|
2.77
|
|
$
|
348
|
|
|
Exercisable at March 31, 2019
|
|
1,466
|
|
|
$
|
9.29
|
|
|
1.56
|
|
$
|
283
|
|
|
|
|
Number of Restricted Stock Units
|
|
Weighted Average Grant Date Fair Value
|
|
Weighted Average Remaining Service
(Years) |
|
Aggregate
Intrinsic Value |
|||||
|
Outstanding as of December 31, 2018
|
|
1,091
|
|
|
$
|
10.97
|
|
|
0.67
|
|
$
|
9,773
|
|
|
Granted
|
|
458
|
|
|
$
|
9.50
|
|
|
|
|
|
|
|
|
Released
|
|
(698
|
)
|
|
$
|
11.38
|
|
|
|
|
|
|
|
|
Forfeited
|
|
(50
|
)
|
|
$
|
9.89
|
|
|
|
|
|
|
|
|
Outstanding at March 31, 2019
|
|
801
|
|
|
$
|
9.84
|
|
|
1.71
|
|
$
|
6,754
|
|
|
|
|
Number of Restricted Stock Awards
|
|
Weighted Average Grant Date Fair Value
|
|
Weighted Average Remaining Recognition Period
(Years) |
|||
|
Outstanding as of December 31, 2018
|
|
55
|
|
|
$
|
13.02
|
|
|
0.46
|
|
Granted
|
|
8
|
|
|
$
|
9.94
|
|
|
|
|
Released
|
|
—
|
|
|
$
|
—
|
|
|
|
|
Forfeited
|
|
—
|
|
|
$
|
—
|
|
|
|
|
Outstanding at March 31, 2019
|
|
63
|
|
|
$
|
12.63
|
|
|
0.23
|
|
|
|
Three Months Ended
March 31, |
||||||
|
|
|
2019
|
|
2018
|
||||
|
Stock options
|
|
$
|
194
|
|
|
$
|
318
|
|
|
RSUs and RSAs
|
|
1,888
|
|
|
879
|
|
||
|
Employee stock purchases
|
|
21
|
|
|
25
|
|
||
|
Total
|
|
$
|
2,103
|
|
|
$
|
1,222
|
|
|
|
|
|
|
|
||||
|
Sales and marketing
|
|
$
|
320
|
|
|
$
|
(67
|
)
|
|
Research and development
|
|
630
|
|
|
256
|
|
||
|
General and administrative
|
|
1,153
|
|
|
1,033
|
|
||
|
Total
|
|
$
|
2,103
|
|
|
$
|
1,222
|
|
|
|
|
Unrealized Gains & Losses on Available for sale
|
|
Foreign Currency Items
|
|
Total
|
||||||
|
Balance as December 31, 2018
|
|
$
|
(6
|
)
|
|
$
|
122
|
|
|
$
|
116
|
|
|
Amounts reclassified from accumulated other comprehensive income
|
|
6
|
|
|
—
|
|
|
6
|
|
|||
|
Net current period other comprehensive income
|
|
6
|
|
|
—
|
|
|
6
|
|
|||
|
Ending balance
|
|
$
|
—
|
|
|
$
|
122
|
|
|
$
|
122
|
|
|
|
|
Three Months Ended March 31,
|
||||||
|
|
|
2019
|
|
2018
|
||||
|
Income (loss) before provision for income taxes
|
|
$
|
(10,901
|
)
|
|
$
|
70,336
|
|
|
Provision for income taxes
|
|
$
|
(115
|
)
|
|
$
|
(453
|
)
|
|
Effective tax rate
|
|
(1.1
|
)%
|
|
0.6
|
%
|
||
|
|
|
Three Months Ended March 31,
|
||||||
|
|
|
2019
|
|
2018
|
||||
|
Numerator:
|
|
|
|
|
||||
|
Net income (loss)
|
|
$
|
(11,016
|
)
|
|
$
|
69,883
|
|
|
Denominator:
|
|
|
|
|
||||
|
Weighted-average common stock outstanding, basic
|
|
31,089
|
|
|
29,700
|
|
||
|
Dilutive effect of potential common shares:
|
|
|
|
|
||||
|
Stock options, RSUs, RSA and ESPP
|
|
—
|
|
|
866
|
|
||
|
Total shares, diluted
|
|
31,089
|
|
|
30,566
|
|
||
|
Basic net income (loss) per share
|
|
$
|
(0.35
|
)
|
|
$
|
2.35
|
|
|
Diluted net income (loss) per share
|
|
$
|
(0.35
|
)
|
|
$
|
2.29
|
|
|
|
|
March 31, 2019
|
|
|
Stock options
|
|
2,268
|
|
|
RSUs
|
|
63
|
|
|
RSAs
|
|
801
|
|
|
|
Balance Sheets Classification
|
|
March 31, 2019
|
|
January 1, 2019
|
||||
|
Assets
|
|
|
|
|
|
||||
|
Operating lease assets
|
Other assets
|
|
$
|
3,828
|
|
|
$
|
4,048
|
|
|
Liabilities
|
|
|
|
|
|
||||
|
Operating lease liabilities - current
|
Other current liabilities
|
|
1,165
|
|
|
1,157
|
|
||
|
Operating lease liabilities - long-term
|
Other long-term liabilities
|
|
3,445
|
|
|
3,693
|
|
||
|
Total lease liabilities
|
|
|
$
|
4,610
|
|
|
$
|
4,850
|
|
|
Cash paid within operating cash flow
|
|
$281
|
|
Weighted average lease terms (in years)
|
|
4.08
|
|
For the Years Ending December 31,
|
|
|
||
|
2019
|
|
$
|
947
|
|
|
2020
|
|
1,209
|
|
|
|
2021
|
|
1,189
|
|
|
|
2022
|
|
1,166
|
|
|
|
2023
|
|
452
|
|
|
|
Thereafter
|
|
24
|
|
|
|
Total
|
|
$
|
4,987
|
|
|
|
Three Months Ended March 31
|
|
|
||||||||
|
|
2019
|
|
2018
|
|
Change
|
|
% Change
|
||||
|
Revenues:
|
|
|
|
|
|
|
|
||||
|
Fixed fee license revenue
|
1,740
|
|
|
75,756
|
|
|
(74,016
|
)
|
|
(98
|
)%
|
|
Per-unit royalty revenue
|
3,307
|
|
|
9,579
|
|
|
(6,272
|
)
|
|
(65
|
)%
|
|
Total royalty and license revenue
|
5,047
|
|
|
85,335
|
|
|
(80,288
|
)
|
|
(94
|
)%
|
|
Development, services, and other
|
75
|
|
|
81
|
|
|
(6
|
)
|
|
(7
|
)%
|
|
Total revenues
|
5,122
|
|
|
85,416
|
|
|
(80,294
|
)
|
|
(94
|
)%
|
|
|
|
Three Months Ended
March 31, |
|
|
||||||||
|
|
|
2019
|
|
2018
|
Change
|
% Change
|
||||||
|
Sales and marketing
|
|
$
|
1,609
|
|
|
$
|
1,220
|
|
389
|
|
32
|
%
|
|
% of total revenue
|
|
32
|
%
|
|
1
|
%
|
|
|
||||
|
Research and development
|
|
$
|
2,302
|
|
|
$
|
2,820
|
|
(518
|
)
|
(18
|
)%
|
|
% of total revenue
|
|
45
|
%
|
|
3
|
%
|
|
|
||||
|
General and administrative
|
|
$
|
12,695
|
|
|
$
|
11,236
|
|
1,459
|
|
13
|
%
|
|
% of total revenue
|
|
248
|
%
|
|
13
|
%
|
|
|
||||
|
|
|
Three Months Ended
March 31, |
|
|
|||||||||||
|
|
|
2019
|
|
2018
|
|
Change
|
|
% Change
|
|||||||
|
Income (loss) before provision for income taxes
|
|
$
|
(10,901
|
)
|
|
$
|
70,336
|
|
|
|
|
|
|||
|
Provision for income taxes
|
|
(115
|
)
|
|
(453
|
)
|
|
$
|
338
|
|
|
(75
|
)%
|
||
|
Effective tax rate
|
|
(1.1
|
)%
|
|
0.6
|
%
|
|
|
|
|
|||||
|
|
|
Three Months Ended March 31,
|
||||
|
|
|
2019
|
|
2018
|
||
|
Net cash provided by (used in) operating activities
|
|
(7,578
|
)
|
|
86,203
|
|
|
Net cash provided by (used in) investing activities
|
|
(936
|
)
|
|
2,133
|
|
|
Net cash provided by financing activities
|
|
180
|
|
|
6,170
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exhibit
Number
|
|
Exhibit Description
|
|
Incorporated by Reference
|
|
Filed
Herewith
|
||||||
|
|
|
Form
|
|
File No.
|
|
Exhibit
|
|
Filing Date
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
X
|
||
|
|
|
|
|
|
|
|
|
|
|
X
|
||
|
|
|
|
|
|
|
|
|
|
|
X
|
||
|
|
|
|
|
|
|
|
|
|
|
X
|
||
|
101.INS
|
|
XBRL Report Instance Document
|
|
|
|
|
|
|
|
|
|
X
|
|
101.SCH
|
|
XBRL Taxonomy Extension Schema Document
|
|
|
|
|
|
|
|
|
|
X
|
|
101.CAL
|
|
XBRL Taxonomy Calculation Linkbase Document
|
|
|
|
|
|
|
|
|
|
X
|
|
101.DEF
|
|
XBRL Taxonomy Extension Definition Linkbase Document
|
|
|
|
|
|
|
|
|
|
X
|
|
101.LAB
|
|
XBRL Taxonomy Label Linkbase Document
|
|
|
|
|
|
|
|
|
|
X
|
|
101.PRE
|
|
XBRL Presentation Linkbase Document
|
|
|
|
|
|
|
|
|
|
X
|
|
*
|
This certification is deemed not filed for purposes of section 18 of the Exchange Act, as amended, or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act, as amended, or the Exchange Act, as amended.
|
|
|
|
IMMERSION CORPORATION
|
|
||
|
Date:
|
May 10, 2019
|
By:
|
/s/ ANNE MARIE PETERS
|
||
|
|
|
|
Anne Marie Peters
|
||
|
|
|
|
Interim Chief Financial Officer
|
||
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|